P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL

Conflict of interest: No Introduction and Objectives: Hepatocellular carcinoma (HCC) with low tumor burden can be treated by liver transplantation (LT). Downstaging is a strategy to reduce tumor burden and allow transplantation. Objectives: To present the features and outcomes of patients undergoing...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Ignacio Marin-Zuluaga, Andres Fernando Rodriguez-Gutierrez, María Fernanda Saavedra-Chacón, Christian Ernesto Melgar-Burbano
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124004617
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850168484806262784
author Juan Ignacio Marin-Zuluaga
Andres Fernando Rodriguez-Gutierrez
María Fernanda Saavedra-Chacón
Christian Ernesto Melgar-Burbano
author_facet Juan Ignacio Marin-Zuluaga
Andres Fernando Rodriguez-Gutierrez
María Fernanda Saavedra-Chacón
Christian Ernesto Melgar-Burbano
author_sort Juan Ignacio Marin-Zuluaga
collection DOAJ
description Conflict of interest: No Introduction and Objectives: Hepatocellular carcinoma (HCC) with low tumor burden can be treated by liver transplantation (LT). Downstaging is a strategy to reduce tumor burden and allow transplantation. Objectives: To present the features and outcomes of patients undergoing LT with a downstaging and to compare them with patients transplanted according to Milan criteria Patients / Materials and Methods: Retrospective cohort study of transplanted patients from July 2012 to January 2024 in a Colombian hospital. Downstaging was carried out in accordance with UNOS criteria. Death and recurrence of HCC were the primary outcomes. Cox proportional hazards model was adjusted for age and Child-Pugh score. Results and Discussion: 79 patients, 17 in downstaging group (DG) and 62 in Milan Group (MG). All patients had cirrhosis. Median age was 60 years and 71% were men. DG has less diabetes mellitus than MG (24% vs. 48%), less comorbidities (82% vs. 92%), better Child-Pugh, less ascites (6% vs. 50%), less encephalopathy (18% vs. 45%) and less variceal bleeding (17% vs. 32%). In DG, the median number of tumors was 2 (IQR: 1-3, 29% with just one) and in MG it was 1 (IQR: 1-1, 79% with just one). Dowstaging was performed using either TACE alone (88%) or in combination with radiofrequency ablation (22%). Liver specimens showed a high sum of tumor diameters in DG (4.8 cm vs. 3.0 cm), however, DG had less microvascular invasion (18% vs. 37%) and a better profile of tumor differentiation. Recurrence was 11.8% in DG and 8.2% in MG (p-value = 0.926, figure). In DG, there was a death rate of 6% while in MG it was 18% (p-value = 0.285). Conclusions: Downstaging appeared to be a successful strategy for LT that could be used to expand the Milan Criteria in Colombia. Less sick patients in DG (necessary for locoregional therapy), could have favored survival.
format Article
id doaj-art-d018917212354e58afddd3eac8406880
institution OA Journals
issn 1665-2681
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj-art-d018917212354e58afddd3eac84068802025-08-20T02:20:57ZengElsevierAnnals of Hepatology1665-26812024-12-012910167810.1016/j.aohep.2024.101678P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITALJuan Ignacio Marin-Zuluaga0Andres Fernando Rodriguez-Gutierrez1María Fernanda Saavedra-Chacón2Christian Ernesto Melgar-Burbano3Hospital Pablo Tobón Uribe, Medellín, ColombiaUniversidad de Antioquia, Medellín, ColombiaUniversidad de Antioquia, Medellín, ColombiaUniversidad de Antioquia, Medellín, ColombiaConflict of interest: No Introduction and Objectives: Hepatocellular carcinoma (HCC) with low tumor burden can be treated by liver transplantation (LT). Downstaging is a strategy to reduce tumor burden and allow transplantation. Objectives: To present the features and outcomes of patients undergoing LT with a downstaging and to compare them with patients transplanted according to Milan criteria Patients / Materials and Methods: Retrospective cohort study of transplanted patients from July 2012 to January 2024 in a Colombian hospital. Downstaging was carried out in accordance with UNOS criteria. Death and recurrence of HCC were the primary outcomes. Cox proportional hazards model was adjusted for age and Child-Pugh score. Results and Discussion: 79 patients, 17 in downstaging group (DG) and 62 in Milan Group (MG). All patients had cirrhosis. Median age was 60 years and 71% were men. DG has less diabetes mellitus than MG (24% vs. 48%), less comorbidities (82% vs. 92%), better Child-Pugh, less ascites (6% vs. 50%), less encephalopathy (18% vs. 45%) and less variceal bleeding (17% vs. 32%). In DG, the median number of tumors was 2 (IQR: 1-3, 29% with just one) and in MG it was 1 (IQR: 1-1, 79% with just one). Dowstaging was performed using either TACE alone (88%) or in combination with radiofrequency ablation (22%). Liver specimens showed a high sum of tumor diameters in DG (4.8 cm vs. 3.0 cm), however, DG had less microvascular invasion (18% vs. 37%) and a better profile of tumor differentiation. Recurrence was 11.8% in DG and 8.2% in MG (p-value = 0.926, figure). In DG, there was a death rate of 6% while in MG it was 18% (p-value = 0.285). Conclusions: Downstaging appeared to be a successful strategy for LT that could be used to expand the Milan Criteria in Colombia. Less sick patients in DG (necessary for locoregional therapy), could have favored survival.http://www.sciencedirect.com/science/article/pii/S1665268124004617
spellingShingle Juan Ignacio Marin-Zuluaga
Andres Fernando Rodriguez-Gutierrez
María Fernanda Saavedra-Chacón
Christian Ernesto Melgar-Burbano
P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
Annals of Hepatology
title P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
title_full P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
title_fullStr P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
title_full_unstemmed P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
title_short P-64 DOWNSTAGING STRATEGY FOR LIVER TRANSPLANTATION IN HEPATOCELLULAR CARCINOMA. A COHORT STUDY IN A COLOMBIAN HOSPITAL
title_sort p 64 downstaging strategy for liver transplantation in hepatocellular carcinoma a cohort study in a colombian hospital
url http://www.sciencedirect.com/science/article/pii/S1665268124004617
work_keys_str_mv AT juanignaciomarinzuluaga p64downstagingstrategyforlivertransplantationinhepatocellularcarcinomaacohortstudyinacolombianhospital
AT andresfernandorodriguezgutierrez p64downstagingstrategyforlivertransplantationinhepatocellularcarcinomaacohortstudyinacolombianhospital
AT mariafernandasaavedrachacon p64downstagingstrategyforlivertransplantationinhepatocellularcarcinomaacohortstudyinacolombianhospital
AT christianernestomelgarburbano p64downstagingstrategyforlivertransplantationinhepatocellularcarcinomaacohortstudyinacolombianhospital